158 related articles for article (PubMed ID: 34034944)
1. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
[TBL] [Abstract][Full Text] [Related]
2. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
Ametsbichler P; Böhlandt A; Nowak D; Schierl R
Eur J Surg Oncol; 2018 Nov; 44(11):1793-1799. PubMed ID: 29871821
[TBL] [Abstract][Full Text] [Related]
3. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
[TBL] [Abstract][Full Text] [Related]
4. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow.
Delhorme JB; Klipfel A; D'Antonio F; Greget MC; Diemunsch P; Rohr S; Romain B; Brigand C
J Visc Surg; 2019 Dec; 156(6):485-488. PubMed ID: 31296454
[TBL] [Abstract][Full Text] [Related]
5. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects.
Solass W; Giger-Pabst U; Zieren J; Reymond MA
Ann Surg Oncol; 2013 Oct; 20(11):3504-11. PubMed ID: 23765417
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).
Kakchekeeva T; Demtröder C; Herath NI; Griffiths D; Torkington J; Solaß W; Dutreix M; Reymond MA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):592-598. PubMed ID: 26842487
[TBL] [Abstract][Full Text] [Related]
7. Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature.
Winkler CS; Sandhu J; Pettke E; Merchea A; Fong Y; Kumara HMCS; Whelan RL
Dis Colon Rectum; 2020 Feb; 63(2):242-255. PubMed ID: 31914116
[TBL] [Abstract][Full Text] [Related]
8. Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases.
Taibi A; Teixeira Farinha H; Durand Fontanier S; Sayedalamin Z; Hübner M; Sgarbura O
Ann Surg Oncol; 2021 Jul; 28(7):3852-3860. PubMed ID: 33216263
[TBL] [Abstract][Full Text] [Related]
9. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.
Larroque M; Arnaudguilhem C; Bouyssiere B; Quenet F; Bouazza N; Jarlier M; Boulabas S; Mounicou S; Sgarbura O
Toxicol Appl Pharmacol; 2021 Oct; 429():115694. PubMed ID: 34428445
[TBL] [Abstract][Full Text] [Related]
11. Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination.
Ndaw S; Hanser O; Kenepekian V; Vidal M; Melczer M; Remy A; Robert A; Bakrin N
Toxicol Lett; 2018 Dec; 298():171-176. PubMed ID: 29852276
[TBL] [Abstract][Full Text] [Related]
12. Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): first in-human application.
Reymond M; Demtroeder C; Solass W; Winnekendonk G; Tempfer C
Pleura Peritoneum; 2016 Jun; 1(2):109-116. PubMed ID: 30911614
[No Abstract] [Full Text] [Related]
13. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Willaert W; Sessink P; Ceelen W
Pleura Peritoneum; 2017 Sep; 2(3):121-128. PubMed ID: 30911641
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
[TBL] [Abstract][Full Text] [Related]
15. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
16. Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model.
Jung W; Park M; Park SJ; Lee EJ; Kim HS; Chung SH; Yoon C
Saf Health Work; 2023 Jun; 14(2):237-242. PubMed ID: 37389318
[TBL] [Abstract][Full Text] [Related]
17. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video).
Cazauran JB; Alyami M; Lasseur A; Gybels I; Glehen O; Bakrin N
J Gastrointest Surg; 2018 Feb; 22(2):374-375. PubMed ID: 28900843
[TBL] [Abstract][Full Text] [Related]
18. The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe.
Nowacki M; Zegarski W
J Int Med Res; 2018 Sep; 46(9):3748-3758. PubMed ID: 29916281
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of exposure risk for healthcare personnel performing the open technique HIPEC procedure using cisplatin.
Zhengzheng Xie MS; Li Y; Yan D; Hu X; Liu Liu MS; Lulu Sun BS; Tao X; Yan D; Ping Yang MS; Zhang Z
Gynecol Oncol; 2021 Apr; 161(1):261-263. PubMed ID: 33526257
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
